Karyopharm Therapeutics
Karyopharm Therapeutics is a commercial-stage pharmaceutical company developing and commercializing cancer therapies targeting nuclear export. Its marketed medicine is XPOVIO (selinexor).
Key facts
| CAGE Code | 7FSV2 |
|---|---|
| Legal Name | Karyopharm Therapeutics Inc. |
| Company Operating Status | Active |
| Full Address | 85 WELLS AVE FL 2 NEWTON, MA 02459 UNITED STATES |
| Stock Symbol | KPTI |
| Ticker Symbol | KPTI |
| Wellfound ID | karyopharm-therapeutics |
Contact details
Email and phone for Karyopharm Therapeutics are available to signed-in members of CliffBio.
Sign in to view